First Mental Health Supplement To Boost Neuroplasticity And Enhance Ketamine Therapy Outcomes

(MENAFN- PR Newswire) This innovative formula is the first of its kind to work synergistically with ketamine therapy-one of the fastest-growing treatments for depression and anxiety-while also offering standalone benefits for individuals seeking natural support for mood regulation, stress reduction, and cognitive performance.

Newy's formulation features four clinically studied ingredients that target key pathways for brain and emotional health. Its hero compound, agmatine sulfate, has shown antidepressant effects in preclinical and clinical studies, reversing depression-like behaviors and supporting neuroplasticity. Research also suggests agmatine enhances ketamine's antidepressant and anxiolytic effects, synergistically extending benefits between sessions and optimizing long-term outcomes.

"As a physician specializing in ketamine therapy, I saw firsthand how patients needed additional tools to maintain progress between treatments," said Dr. Rivas, co-founder and CEO of Newy. "This formula not only supports individuals undergoing ketamine therapy but also offers meaningful benefits for anyone seeking to enhance their mood, promote nervous system balance, and support long-term brain health".

The need for innovative mental health solutions is urgent. According to the National Institute of Mental Health, major depressive disorder affects approximately 21 million U.S. adults annually, and nearly one-third of these individuals experience treatment-resistant depression (TRD)-a condition that fails to respond to standard antidepressants. Newy's integrative approach aims to bridge this gap by pairing evidence-based nutrition with modern therapeutic strategies.

Newy is manufactured in GMP-certified facilities in New York, and undergoes rigorous third-party testing for purity and allergens. The formula meets clean-label standards-certified vegan, gluten-free, soy-free, and non-GMO-and uses therapeutic doses of each ingredient to ensure both safety and effectiveness.

The supplement is available exclusively online at with nationwide shipping.

About Newy

Founded in 2024 by Dr. Ray Rivas, a board-certified physician and ketamine specialist, and Libby Rivas, Newy is committed to developing effective, science-backed supplements that promote mood balance and cognitive health. By combining clinical expertise with personal insight, Newy empowers individuals to support their mental well-being through transparent, evidence-based nutrition.

SOURCE Newy

MENAFN28082025003732001241ID1109988671